期刊文献+

甲泼尼龙、丙种球蛋白联合冲击治疗多发性硬化14例疗效分析 被引量:6

Effect of High-doses of Intravenous Methylprednisolone Therapy Associated with Gamma Globulin in 14 Multiple Sclerosis Cases
下载PDF
导出
摘要 目的 分析大剂量甲泼尼龙联合丙种球蛋白冲击治疗多发性硬化 ( MS)的临床疗效。方法 对 1 994—2 0 0 2年采用大剂量甲泼尼龙、丙种球蛋白联合冲击治疗的 1 4例复发 -缓解型 MS患者进行回顾性分析。应用SPSS1 0 .0 ,进行两独立样本的 t检验。结果 治疗组见效时间、缓解时间、平均住院天数分别为 ( 4 .0± 1 .6)、( 2 1 .2± 3 .2 )、( 2 5 .0± 5 .9) d,均较对照组短 ( P <0 .0 5 )。结论 对于复发 -缓解型 MS,大剂量甲泼尼龙、丙种球蛋白联合冲击治疗可取得较好的疗效。 Objective To analyze retrospectively the therapeutic efficacy of 14 cases of multiple sclerosis (MS), by high doses of intravenous methylprednisolone associated with gamma globulin.Methods 14 cases of relapsing-remitting MS were carried out with two-independent-samples t test by SPSS 10.0 for windows. Results For the treatment group, coming effective time:(4.0±1.6) days(P<0.05); remitting time: (21.2±3.2) days(P<0.05); admission time: (25.0±5.9) days(P< 0.05).Conclusions For relapsing-remitting type, therapeutic efficacy of the treatment group is superior to the control group.
作者 马琦 王彤歌
出处 《中国神经免疫学和神经病学杂志》 CAS 2003年第3期183-185,共3页 Chinese Journal of Neuroimmunology and Neurology
关键词 多发性硬化 甲泼尼龙 丙种球蛋白 multiple sclerosis methylprednisolone gamma globulin
  • 相关文献

参考文献6

  • 1Schmidt J,Gold R, Schnrock L,et al. T-cell apoptosis in situ in experimental autoimmune encephalo-myelitis following methylprednisolone pulse therapy[J]. Brain, 2000,123:1431-1441.
  • 2Leussink VI, Jung S,Merschdorf U,et al. High-dose methylprednisolone therapy in multiple sclerosis induces apoptosis in peripheral blood leukocytes[J]. Arch Neurol, 2001,58(1):91-97.
  • 3周文斌,朱世津,汤新年,杨欢,肖波,谢光洁.甲基强的松龙对多发性硬化免疫功能的影响[J].中国神经免疫学和神经病学杂志,2000,7(3):152-156. 被引量:21
  • 4Griftths TD,Newman PK. Steroids in multiple sclerosis[J]. J Clin Pharm Ther, 1994,19(4):219-222.
  • 5Martínez-Cáceres EM,Barrau MA,Brieva L,et al. Treatment with methylprednisolone in relapses of multiple sclerosis patients: immunological evidence of immediate and short-term but not long-lasting effects[J]. Clin Exp Immunol, 2002,127(1):165-171.
  • 6田作军,赵薛旭,李作汉.不同免疫疗法对多发性硬化疗效的探讨[J].脑与神经疾病杂志,2001,9(5):300-302. 被引量:8

二级参考文献27

  • 1[1] Ffrench-Constant C. Pathogenesis of multiple sclerosis[J]. Lancet, 1994,343:271-275.
  • 2[2] Beck J,Rondot P, Catinot L,et al. Increased production of interferon gamma and tumor necrosis factor precedes clinical manifestation in multiple sclerosis: do cytokines trigger off exacerbations?[J] Acta Neurol Scand, 1988,78:318-323.
  • 3[3] Griftths TD, Newman PK. Steroids in multiple sclerosis[J]. J Clin Pharm Ther, 1994,19:219-222.
  • 4[4] Poser CM , Paly UM, Scheinbre L. New diagnostic criteria for multiple sclerosis guidelines for research protocols[J]. Ann Neurol, 1983,13:227-231.
  • 5[5] Yagi Y, Takahashi M, Nakamura Y. Cytokine-secreting cells in relapsing multiple sclerosis patients treated with high-dose intravenous methylprednisolone[J]. Rinsho Shinkeigaku, 1997,37(7):575-579.
  • 6[6] Gelati M, Corsini E, Dufour A, et al. Reduced adhesion of PBMNCs to endothelium in methylprednisolone-treated MS patients: preliminary results[J]. Acta Neurol Scand, 1997,96(5):283-392.
  • 7[7] De Waat-Malefyt R, Haanen J, Spits H,et al. Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class Ⅱ major histocompatibility complexes expression[J]. J Exp Med, 1991,174:915-924.
  • 8[9] Gayo A, Mozo L, Sulez A, et al. Glucocorticoids increase IL-10 expression in multiple sclerosis patients with acute relapse[J]. J Neuroimmunol, 1998,85:122-30.
  • 9[1]Poser CM, Paty TW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis: guildeline for research protocols[J ]. Ann Neurol, 1983,13:227~231
  • 10[2]Lublin FD, Reingold SC. N eurology, 1996,46:907~911

共引文献24

同被引文献24

引证文献6

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部